content

China grants country’s first Covid-19 vaccine patent to CanSino

China's vaccine maker CanSino Biologics Inc has won a patent approval from Beijing for its COVID-19 vaccine candidate Ad5-nCOV, People's Daily reported, citing documents...

Covaxin: Bharat Biotech-ICMR developed vaccine is safe, show preliminary results

The preliminary results of phase 1 clinical trials of Bharat Biotech-ICMR developed Covaxin, a COVID-19 vaccine, has shown that the vaccine is safe. The...

Russia’s COVID-19 vaccine to enter production, deliver first batch of doses in two weeks

The world's first vaccine registered by Russian authorities, and now the World Health Organisation has said it is in talks with Russia's health ministry...

TIACA and Pharma.Aero Join Forces to Prepare Air Cargo Industry for COVID-19 Vaccine

The International Air Cargo Association (TIACA) and Pharma.Aero have joined forces to develop global guidance for the air cargo industry to enable optimal transportation...

FDA Accepts Biogens Aducanumab Biologics License Application for Alzheimer’s Disease with Priority Review

Biogen and Eisai, Co., Ltd. announced that the U.S. FDA has accepted the Biologics License Application (BLA) for aducanumab, an investigational treatment for Alzheimer’s...

Regeneron Announces FDA Accepts Evinacumab BLA for Priority Review as Treatment for Patients with HoFH

Regeneron Pharmaceuticals, Inc. announced that the U.S. FDA has accepted for Priority Review a Biologics License Application (BLA) for evinacumab as an adjunct to...

Caprion-HistoGeneX, Viroclinics-DDL Announce COVID-19 Research Partnership

Caprion-HistoGeneX and Viroclinics-DDL announced a new strategic partnership to expand their global capabilities addressing the emerging needs for therapeutic and prophylactic solutions to target...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read